10-Q quarterly report · filed Nov 12, 2026

LifeMD, Inc. (LFMD) Q3 2026 10-Q Quarterly Report

Short answer

LifeMD, Inc. (LFMD) filed its Q3 2026 10-Q quarterly report on Nov 12, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $45M (down 24.5% year over year) with net income of −$5M.

Q3 2026 key financials · XBRL

Revenue
$45M
−24.5% YoY · −5.7% QoQ
Net income
−$5M
+5.9% YoY · +34.7% QoQ
Operating margin
-10.4%
Gross margin
81.2%
EPS (diluted)
−$0.11
+35.3% QoQ

Source: XBRL data from the LifeMD, Inc. (LFMD) Q3 2026 10-Q on SEC EDGAR. USD.

LifeMD, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $44.6M, down 7% YoY from $47.7M, driven by lower telehealth product demand
  • Gross margin 81.51% vs 85.20% YoY, operating margin (10.01)% vs (6.55)%
  • Telehealth product revenue weakest, down approximately $3.2M YoY; subscription revenue strongest, up $1.3M over nine months
  • Cash $21.9M at September 30, 2026, down $14.9M; operating cash flow used $7.4M vs $11.6M provided YoY
  • Outlook: existing cash and Avenue financing expected to fund operations and capital expenditures for at least 12 months; risks include demand and regulatory changes

Risk Factors

  • No material changes to risk factors since the December 31, 2025 Form 10-K
  • Carried-forward risks could adversely affect business, operating results, and financial condition
  • Investment risk remains significant for common-stock purchasers

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other LifeMD, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.